Consolini Rita, Legitimo Annalisa, Caparello Maria Costanza
Laboratory of Immunology, Department of Clinical and Experimental Medicine, Division of Pediatrics, University of Pisa , Pisa , Italy.
Front Pediatr. 2016 Oct 19;4:102. doi: 10.3389/fped.2016.00102. eCollection 2016.
The natural history of the immune thrombocytopenia (ITP) is interesting and intriguing because it traces different steps underlying autoimmune diseases. The review points out the main steps that have accompanied the stages of its history and the consequential changes related to its terminology. ITP is an autoimmune disease resulting from platelet antibody-mediated destruction and impaired megakaryocyte and platelet production. However, research advances highlight that a complex dysregulation of the immune system is involved in the pathogenesis of this condition. The review examines the role of the multiple immune components involved in the autoimmunity process, focusing on the more recent mechanisms, which could be new promising therapeutic targets for ITP patients.
免疫性血小板减少症(ITP)的自然病史既有趣又引人入胜,因为它追踪了自身免疫性疾病背后的不同步骤。这篇综述指出了伴随其病史各阶段的主要步骤以及与其术语相关的相应变化。ITP是一种自身免疫性疾病,由血小板抗体介导的破坏以及巨核细胞和血小板生成受损所致。然而,研究进展表明,免疫系统的复杂失调参与了该病症的发病机制。这篇综述探讨了参与自身免疫过程的多种免疫成分的作用,重点关注了最新机制,这些机制可能成为ITP患者新的有前景的治疗靶点。